Cargando…

Natural resistance against infections: focus on COVID-19

Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Netea, Mihai G., Domínguez-Andrés, Jorge, van de Veerdonk, Frank L., van Crevel, Reinout, Pulendran, Bali, van der Meer, Jos W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648669/
https://www.ncbi.nlm.nih.gov/pubmed/34924297
http://dx.doi.org/10.1016/j.it.2021.12.001
_version_ 1784610857002467328
author Netea, Mihai G.
Domínguez-Andrés, Jorge
van de Veerdonk, Frank L.
van Crevel, Reinout
Pulendran, Bali
van der Meer, Jos W.M.
author_facet Netea, Mihai G.
Domínguez-Andrés, Jorge
van de Veerdonk, Frank L.
van Crevel, Reinout
Pulendran, Bali
van der Meer, Jos W.M.
author_sort Netea, Mihai G.
collection PubMed
description Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We propose that natural resistance is part of the disease history in some individuals exposed to this new coronavirus. Epidemiological arguments for natural resistance to SARS-CoV-2 are the lower seropositivity of children compared to adults, studies on closed environments of ships with outbreaks, and prevalence studies in some developing countries. Potential mechanisms of natural resistance include host genetic variants, viral interference, cross-protective natural antibodies, T cell immunity, and highly effective innate immune responses. Better understanding of natural resistance can help to advance preventive and therapeutic measures against infections for improved preparedness against potential future pandemics.
format Online
Article
Text
id pubmed-8648669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86486692021-12-07 Natural resistance against infections: focus on COVID-19 Netea, Mihai G. Domínguez-Andrés, Jorge van de Veerdonk, Frank L. van Crevel, Reinout Pulendran, Bali van der Meer, Jos W.M. Trends Immunol Opinion Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We propose that natural resistance is part of the disease history in some individuals exposed to this new coronavirus. Epidemiological arguments for natural resistance to SARS-CoV-2 are the lower seropositivity of children compared to adults, studies on closed environments of ships with outbreaks, and prevalence studies in some developing countries. Potential mechanisms of natural resistance include host genetic variants, viral interference, cross-protective natural antibodies, T cell immunity, and highly effective innate immune responses. Better understanding of natural resistance can help to advance preventive and therapeutic measures against infections for improved preparedness against potential future pandemics. Elsevier Ltd. 2022-02 2021-12-07 /pmc/articles/PMC8648669/ /pubmed/34924297 http://dx.doi.org/10.1016/j.it.2021.12.001 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Opinion
Netea, Mihai G.
Domínguez-Andrés, Jorge
van de Veerdonk, Frank L.
van Crevel, Reinout
Pulendran, Bali
van der Meer, Jos W.M.
Natural resistance against infections: focus on COVID-19
title Natural resistance against infections: focus on COVID-19
title_full Natural resistance against infections: focus on COVID-19
title_fullStr Natural resistance against infections: focus on COVID-19
title_full_unstemmed Natural resistance against infections: focus on COVID-19
title_short Natural resistance against infections: focus on COVID-19
title_sort natural resistance against infections: focus on covid-19
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648669/
https://www.ncbi.nlm.nih.gov/pubmed/34924297
http://dx.doi.org/10.1016/j.it.2021.12.001
work_keys_str_mv AT neteamihaig naturalresistanceagainstinfectionsfocusoncovid19
AT dominguezandresjorge naturalresistanceagainstinfectionsfocusoncovid19
AT vandeveerdonkfrankl naturalresistanceagainstinfectionsfocusoncovid19
AT vancrevelreinout naturalresistanceagainstinfectionsfocusoncovid19
AT pulendranbali naturalresistanceagainstinfectionsfocusoncovid19
AT vandermeerjoswm naturalresistanceagainstinfectionsfocusoncovid19